TrialDiabetes, obesity & metabolism2020

Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial.

Jordan Kraaijenhof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.